Search

Displaying results 7001 - 7010 of 10000 in total
  1. Drug

    Anumigilimab

    go.drugbank.com/drugs/DB16359
    Investigational

    CSL324 is a fully human anti-G-CSFR antibody shown to have the ability to control G-CSF-mediated neutrophilia in cynomolgus macaques. … [A225626] It has potential applications in various inflammatory conditions such as cystic fibrosis, inflammatory bowel disease, rheumatoid arthritis, and vasculitis.[L27516]

  2. Drug

    DDP-225

    go.drugbank.com/drugs/DB05642
    Investigational

    The unique combination of noradrenaline reuptake inhibition and 5-HT3 antagonism in one orally delivered compound represents a novel approach to treating IBS-d and other functional GI diseases. … Dynogen licensed preclinical and clinical data related to DDP225 from Mitsubishi Pharma in October 2003.

  3. Drug

    Human Interleukin 8

    go.drugbank.com/drugs/DB16456
    Investigational

    Interleukin-8 is under investigation in clinical trial NCT05148234 (BMS-986253 in Myelodysplastic Syndromes).

  4. Drug

    Becocalcidiol

    go.drugbank.com/drugs/DB04891
    Investigational

    Becocalcidiol is a vitamin D(3) analogue which has not caused hypercalcaemia or significant irritation in preclinical trials.

    Categories: Vitamin D and Analogues
  5. Drug

    Peruvoside

    go.drugbank.com/drugs/DB13756
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Oxidized cellulose

    go.drugbank.com/drugs/DB13570
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  7. Drug

    Coumarin 120

    go.drugbank.com/drugs/DB08168
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  8. Drug

    Saralasin

    go.drugbank.com/drugs/DB06763
    Experimental

    Categories: Agents Acting on the Renin-Angiotensin System
  9. Drug

    TD-0903

    go.drugbank.com/drugs/DB16463
    Investigational

    TD-0903 was investigated in clinical trials for its potential to treat acute lung injury (ALI) associated with COVID-19, including NCT04350736, NCT05091723 (a pharmacokinetics study in healthy participants … with supplemental oxygenation), and NCT04402866 (focused on ALI and lung inflammation associated with COVID-19)

  10. Drug

    Terevalefim

    go.drugbank.com/drugs/DB16397
    Investigational

    Terevalefim is under investigation in clinical trial NCT02474667 (Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney).